12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

  • Stoke Therapeutics STOK stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out yesterday.
  • Mesoblast MESO stock moved upwards by 64.95% to $3.63. The market value of their outstanding shares is at $368.2 million.
  • OpGen OPGN shares increased by 42.1% to $0.68. The company's market cap stands at $6.7 million.
  • Alpha Teknova TKNO shares rose 36.92% to $3.3. The market value of their outstanding shares is at $134.6 million.
  • Nuvation Bio NUVB shares moved upwards by 32.22% to $2.98. The company's market cap stands at $651.6 million.
  • Journey Medical DERM stock moved upwards by 28.42% to $3.75. The company's market cap stands at $72.4 million. As per the press release, Q4 earnings came out 3 days ago.

Losers

  • NeuBase Therapeutics NBSE stock declined by 51.8% to $0.48 during Tuesday's regular session. The company's market cap stands at $1.7 million.
  • Prenetics Global PRE shares decreased by 18.23% to $3.68. The company's market cap stands at $44.9 million.
  • Equillium EQ stock decreased by 18.04% to $2.0. The market value of their outstanding shares is at $70.2 million. As per the news, the Q4 earnings report came out yesterday.
  • SCWorx WORX shares fell 17.11% to $2.81. The company's market cap stands at $3.4 million.
  • Monte Rosa Therapeutics GLUE stock decreased by 17.03% to $7.02. The company's market cap stands at $352.0 million.
  • Biodexa Pharmaceuticals BDRX shares decreased by 15.37% to $0.83. The company's market cap stands at $3.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!